ABIN2853593
antibody from antibodies-online
Targeting: CXCR4
CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2853593 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Chemokine (C-X-C Motif) Receptor 4 (CXCR4) (Extracellular Domain), (N-Term) antibody (FITC)
- Antibody type
- Monoclonal
- Description
- Ammonium sulfate precipitation followed by gel filtration through Superdex 200 in PBS
- Reactivity
- Human
- Host
- Rat
- Conjugate
- Green dye
- Epitope
- N-Term, Extracellular Domain
- Isotype
- IgG
- Antibody clone number
- A145
- Vial size
- 100 μL
- Storage
- Store at 2-8°C.
Submitted references Cross-linking cell surface chemokine receptors leads to isolation, activation, and differentiation of monocytes into potent dendritic cells.
Kisspeptin-10-induced signaling of GPR54 negatively regulates chemotactic responses mediated by CXCR4: a potential mechanism for the metastasis suppressor activity of kisspeptins.
A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity.
Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection.
Nimura F, Zhang LF, Okuma K, Tanaka R, Sunakawa H, Yamamoto N, Tanaka Y
Experimental biology and medicine (Maywood, N.J.) 2006 Apr;231(4):431-43
Experimental biology and medicine (Maywood, N.J.) 2006 Apr;231(4):431-43
Kisspeptin-10-induced signaling of GPR54 negatively regulates chemotactic responses mediated by CXCR4: a potential mechanism for the metastasis suppressor activity of kisspeptins.
Navenot JM, Wang Z, Chopin M, Fujii N, Peiper SC
Cancer research 2005 Nov 15;65(22):10450-6
Cancer research 2005 Nov 15;65(22):10450-6
A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity.
Ichiyama K, Yokoyama-Kumakura S, Tanaka Y, Tanaka R, Hirose K, Bannai K, Edamatsu T, Yanaka M, Niitani Y, Miyano-Kurosaki N, Takaku H, Koyanagi Y, Yamamoto N
Proceedings of the National Academy of Sciences of the United States of America 2003 Apr 1;100(7):4185-90
Proceedings of the National Academy of Sciences of the United States of America 2003 Apr 1;100(7):4185-90
Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection.
Tanaka R, Yoshida A, Murakami T, Baba E, Lichtenfeld J, Omori T, Kimura T, Tsurutani N, Fujii N, Wang ZX, Peiper SC, Yamamoto N, Tanaka Y
Journal of virology 2001 Dec;75(23):11534-43
Journal of virology 2001 Dec;75(23):11534-43
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS